Table 2.

lipid abnormalities according to Canadian guideline risk levels (2) in patients with complete lipid profiles

	All patients (n=2393)	High risk* (n=1913)	Intermediate risk* (n=191)	Low risk* (n=289)
LDL-C not at goal/intervention target†	37.0	45.0	11.5	0.7
TC/HDL-C ratio not at goal/intervention target‡	23.3	27.5	13.6	1.4
LDL-C and TC/HDL-C ratio not at goal/intervention target	16.1	19.7	4.2	0.0
Elevated triglycerides§	36.9	37.7	31.4	35.3

Data presented as %.

^*High-risk: coronary artery disease, peripheral arterial disease, cerebrovascular disease, diabetes mellitus or Framingham 10-year risk score 20% or greater. Intermediate risk: Framingham 10-year risk score 10% to 19%. Low-risk: Framingham 10-year risk score less than 10%;

^†Low-density lipoprotein cholesterol (LDL-C) 2.0 mmol/Lor greater in high-risk patients, 3.5 mmol/L or greater in intermediate-risk patients, and 5.0 mmol/L or greater in low-risk patients;

^‡Total cholesterol/ high-density lipoprotein cholesterol (TC/HDL-C) ratio: high risk is 4 or greater, intermediate risk is 5 or greater, low risk is 6 or greater;

^§1.7 mmol/L or greater